Neurocrine Biosciences, Inc. (NBIX) ownership: Top institutional holder: BlackRock, Inc. ($1.76B). Insider activity: Net Seller (0 buys, 20 sells). 2 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BlackRock, Inc. | 13385607.00 | $1.76B | 2026-03-31 |
| VANGUARD GROUP INC | 9700301.00 | $1.38B | 2025-12-31 |
| Dodge & Cox | 5461037.00 | $719.44M | 2026-03-31 |
| JPMORGAN CHASE & CO | 5442067.00 | $700.50M | 2026-03-31 |
| AQR CAPITAL MANAGEMENT LLC | 4938967.00 | $650.66M | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4726344.00 | $622.65M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4511904.00 | $594.40M | 2026-03-31 |
| STATE STREET CORP | 4354526.00 | $573.67M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-05-27 | |
| Sell | null | 2026-05-27 | |
| Sell | null | 2026-05-27 | |
| Sell | null | 2026-05-27 | |
| Sell | null | 2026-05-27 | |
| Sell | null | 2026-05-27 | |
| Sell | null | 2026-05-27 | |
| Sell | null | 2026-05-27 |
Back to NBIX overview · NBIX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.